TETRAPHASE PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Four

TETRAPHASE PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Four

TETRAPHASE PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Four of $400.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.

Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2019-11-12

• 2019-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Four $400.00K.